Junkosha honors Creo Medical CTO as the winner of its its Technology Innovator of the Year Awards – Medical Design and Outsourcing – Medical Design…

The U.K.-based company has created an advanced energy multimodality instrument developed for flexible endoscopy. According to Junkosha, Creo Medicals technology combines the benefits of bipolar RF and super high-frequency microwave energy to provide the ability to dissect, resect, coagulate and inject in a single device producing results that could reduce cancer recurrence.

Chris breakthrough technology holds the potential to transform the point of treatments for a range of cancers. Overall, Chris achievement is one we can use as a yardstick to measure others in future years, said Joe Rowan, Junkoshas president and CEO in the U.S. and Europe.

Said Junkosha CEO Mamoru Sogo: We believe that enabling innovators, like Creo Medical, is central to the philosophy behind the Junkosha brand as we continually look to advance the next generation of technology for a better future. As part of the plans to raise awareness of our new brand internationally, the awards program delivers a tangible commitment to our values.

See the original post here:
Junkosha honors Creo Medical CTO as the winner of its its Technology Innovator of the Year Awards - Medical Design and Outsourcing - Medical Design...